Ocular Symptoms in Kidney, Liver, and Heart Transplant Patients

• Published in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation Vol. 22; no. Suppl 1; pp. 141 - 147
• Main Authors: Sarigul Sezenoz, Almila, Gokgoz, Gulsah, Kirci Dogan, Irem, Gur Gungor, Sirel, Oto, Sibel, Haberal, Mehmet
• Format: Journal Article
• Language: English
• Published: Turkey 01.01.2024
• ISSN: 2146-8427
• DOI: 10.6002/ect.MESOT2023.O34

The purpose of this study was to report the ocular manifestations in kidney, liver, and heart transplant recipients. We reviewed the medical records of kidney, liver, and heart transplant recipients who were examined at the ophthalmology clinic of a tertiary hospital between October 2021 and October 2022. We evaluated the ocular complaints of the patients, ophthalmological examination findings, the etiology of the underlying disease, comorbidities, posttransplant duration, and the medications used. Ocular pathologies were classified as corneal, conjunctival, lens, vitreoretinal, and optic disc pathologies for the analysis. Our study included 233 patients (191 kidney, 40 liver, 2 heart transplant patients). Mean age of patients was 42.94 ± 17.45 years. Among the patient group, 80.3% had at least 1 pathological ocular finding. In subgroup analysis, 12.4% of the patients had corneal pathologies, 19.3% had conjunctival pathologies, 33.0% had lens pathologies, 33.5% had vitreoretinal pathologies, and 18.9% had optic disc-related pathologies. The most common finding was dry eye, followed by cataract and vitreoretinal pathologies. The most common vitreoretinal pathology was diabetic retinopathy, followed by hypertensive retinopathy. The ocular pathology incidence in kidney and liver transplant patients was similar (P = .05). The 2 heart transplant patients did not have any ocular pathologies except refractive errors. In addition, no significant correlation was observed between posttransplant duration and ocular pathologies (P = .28). Ocular findings were seen in most of the kidney and liver transplant recipients. Therefore, it is required that these patients undergo routine ocular screenings in order to facilitate early diagnosis and prompt treatment when needed.